Peptide antibiotic AS-48 was purified to homogeneity by ion-exchange chromatography, gel filtration chromatography, and reversed-phase liquid chromatography. The purified fraction was active against gram-positive and gram-negative bacteria. AS-48 is a basic protein with an isoelectric point of ca. 10.5 and a molecular mass of 7.4 kilodaltons. Its inhibitory activity was markedly affected by sodium dodecyl sulfate and cardiolipin but not by neuraminidase, pectinase, I8-glucosidase, or 0-glucuronidase. Differential scanning calorimetry data suggested that AS-48 molecules lack a compact structure.Since bacteriocin production by group D streptococci was first reported (11), extensive studies have been performed on this subject, many of them describing the production and characterization of different types of classic bacteriocins (2,6,12,16).However, production of peptide antibiotics by members of this group is very unusual, with the exception of nisin (8). This substance and the small bacteriocin C3603 (9) deserve further attention, since they both could be included in a group of strongly basic peptides that display marked antimicrobial activity. It has been suggested that the large number of similar substances from different origins described so far (3,24,27), most of them showing structural and functional similarities, reflects the conservation in the course of evolution of a general mechanism of antibiosis by basic peptides (22).In a previous paper (5), we described the partial purification and characterization of a new antibiotic peptide (AS-48) produced by Streptococcus (Enterococcus) faecalis subsp.liquefaciens S-48. This substance showed potential for inhibition of gram-positive unrelated bacteria and also gramnegative bacteria. In this paper, new data are presented concerning the complete purification and amino acid composition of this substance. Similarities to other basic peptides are also discussed.
MATERIALS AND METHODSMicroorganisms. S. faecalis subsp. liquefaciens S-48 (isolated from a human wound exudate) was used as the producer strain. S. faecalis subsp. liquefaciens S-47 and Escherichia coli U-9, both from our laboratory collection, were used as susceptible strains.Growth media, antibiotic production, and assay of activity. Brain heart infusion (BHI broth; BBL Microbiology Systems, Cockeysville, Md.) was used as the growth medium. Buffered CM-G (5) was used for antibiotic production.The procedures for antibiotic assay and determination of arbitrary units were as previously described (5). The plating medium for the antibiotic assay consisted of Mueller-Hinton agar (BBL). Soft-agar overlay tubes consisted of 0.75% agar * Corresponding author.(Difco Laboratories, Detroit, Mich.). All media were buffered with 0.15 M sodium phosphate, pH 7.2.For antibiotic production, batches of buffered CM-G were inoculated with overnight growth of the producer strain (4% [vol/vol]) and incubated at 37°C for 8 h. The cells were then removed by centrifugation, and the supernatants were purified.Purification of AS-48. Th...